Journal
CHEMISTRY-AN ASIAN JOURNAL
Volume 11, Issue 11, Pages 1648-1657Publisher
WILEY-V C H VERLAG GMBH
DOI: 10.1002/asia.201600259
Keywords
amyloid beta-peptides; cyclodextrins; drug delivery; insulin; sugars
Categories
Funding
- Consorzio Interuniversitario di Ricerca in Chimica dei Metalli nei Sistemi Biologici (CIRCMSB)
- Italian Ministero dell'Universita e della Ricerca [FIRB RINAME RBAP114AMK]
Ask authors/readers for more resources
Cyclodextrins are extensively used in different fields (e.g., catalysis, chromatography, pharma, supramolecular chemistry, bioorganic chemistry, and bioinorganic chemistry), and their applications have been widely reviewed. Their main application in the field of pharmaceutical is as a drug carrier. This review overviews, for the first time, the use of cyclodextrins and their derivatives as antiaggregant agents in a number of proteins (e.g., amyloid-beta, insulin, recombinant human growth hormone, prion protein, transthyretin, and a-synuclein) and some multimeric enzymes. There are many diseases that are correlated to protein misfolding and amyloid formation processes affecting numerous organs and tissues. There are over 30 different amyloid proteins and a number of corresponding diseases. Alzheimer's disease is the most common neurodegenerative disease. Treatment of these diseases is still a goal to reach, and many molecules are studied in this perspective. Cyclodextrins have also been studied, and they show great potential; as such, further studies could be very promising. This review aims to be a stimulus for the design of new cyclodextrin derivatives to obtain multifunctional systems with antiaggregant activity.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available